Improving Graft Outcomes for the Long Term

Presented for attendees of the American Transplant Congress.
This is not an official function/event of the American Transplant Congress.

Accreditation and Designation of Credit
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massachusetts Medical School and Strategically Speaking, Inc. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

The University of Massachusetts Medical School designates this continuing medical education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.    

Fee Information and Acknowledgement
There is no fee for this educational activity, which is supported by an unrestricted educational grant from Novartis Pharmaceuticals Corporation.

Evaluation Form (How to obtain your credit/certificate)
Please complete the enclosed evaluation form upon conclusion of the meeting in order to receive your continuing education credit(s). CME/CE/CEU certificates will be issued 6 to 8 weeks from the meeting date.

Disclosure Policy
It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity, and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use, and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Disclosure of Unlabeled Use and Disclaimer
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. The University of Massachusetts Medical School, Strategically Speaking, Inc., and Novartis Pharmaceuticals Corporation do not recommend the use of any agent outside of the labeled indications.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions, review of possible contraindications, consideration of applicable manufacturer’s product information, and comparison with recommendations of other authorities.